Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma

被引：0
|
作者：
Genhao Zhang
Xianping Lv
Qiankun Yang
Hongchun Liu
机构：
[1] Zhengzhou University First Affiliated Hospital,Department of Blood transfusion
[2] Zhengzhou University First Affiliated Hospital,Department of Medical Laboratory
来源：
BMC Cancer | / 22卷
关键词：
HM13; Prognosis; Immune checkpoint inhibitors; HCC; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma
    Zhang, Genhao
    Lv, Xianping
    Yang, Qiankun
    Liu, Hongchun
    [J]. BMC CANCER, 2022, 22 (01)
  • [2] High expression of HM13 correlates with poor prognosis in hepatocellular carcinoma
    Yan, Lili
    Tan, Zhihui
    Lv, Ji
    Jia, Hongyu
    Li, Shanshan
    Wang, Tao
    Du, Yanan
    Song, Haiyang
    Sun, Jiewei
    Jiang, Wenjin
    Xu, Zhiying
    Xu, Meimei
    [J]. JOURNAL OF MOLECULAR HISTOLOGY, 2024,
  • [3] Phosphogluconate dehydrogenase is a predictive biomarker for immunotherapy in hepatocellular carcinoma
    Liu, Tiantian
    Qi, Jianni
    Wu, Hao
    Wang, Le
    Zhu, Lihui
    Qin, Chengyong
    Zhang, Jiao
    Zhu, Qiang
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] MRPL48 is a novel prognostic and predictive biomarker of hepatocellular carcinoma
    Lin, Yu-Xiang
    Pan, Jun-Yong
    Feng, Wen-Du
    Huang, Tian-Cong
    Li, Cheng-Zong
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [5] MRPL48 is a novel prognostic and predictive biomarker of hepatocellular carcinoma
    Yu-Xiang Lin
    Jun-Yong Pan
    Wen-Du Feng
    Tian-Cong Huang
    Cheng-Zong Li
    [J]. European Journal of Medical Research, 28
  • [6] ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
    Liu, Fahui
    Liang, Jiadong
    Long, Puze
    Zhu, Lilan
    Hou, Wanyun
    Wu, Xueming
    Luo, Chunying
    [J]. FRONTIERS IN ONCOLOGY, 2022, 11
  • [7] SAMD13 serves as a useful prognostic biomarker for hepatocellular carcinoma
    Yoo, Wonbeak
    Kim, Seokho
    Noh, Kyunghee
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [8] SAMD13 serves as a useful prognostic biomarker for hepatocellular carcinoma
    Wonbeak Yoo
    Seokho Kim
    KyungHee Noh
    [J]. European Journal of Medical Research, 28
  • [9] Immunotherapy and drug sensitivity predictive roles of a novel prognostic model in hepatocellular carcinoma
    Gao, Xiaoge
    Ren, Xin
    Wang, Feitong
    Ren, Xinxin
    Liu, Mengchen
    Cui, Guozhen
    Liu, Xiangye
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [10] Identification of METTL3 as an Adverse Prognostic Biomarker in Hepatocellular Carcinoma
    Liu, Gao-Min
    Zeng, Hua-Dong
    Zhang, Cai-Yun
    Xu, Ji-Wei
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (04) : 1110 - 1126
12345